Oric Pharmaceuticals (ORIC)

• Market cap: $372M
• 1 day: -9.34%
• 5 days: -16.83%
• 1 month: -31.41%
• 3 months: -38.71%
• 6 months: -45.07%
• Year to date: -36.56%
• 1 year: -53.99%
• 5 years: -79.67%
• 10 years: -79.67%
• Sector: Healthcare
• Industry: Biotechnology

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

6,175% more call options, than puts

Call options by funds: $3.26M | Put options by funds: $52K

96% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 26

35% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 20

25% more funds holding in top 10

Funds holding in top 10: 4 [Q3] → 5 (+1) [Q4]

8.37% more ownership

Funds ownership: 99.03% [Q3] → 107.4% (+8.37%) [Q4]

6% more funds holding

Funds holding: 122 [Q3] → 129 (+7) [Q4]

15% less capital invested

Capital invested by funds: $715M [Q3] → $612M (-$104M) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $21 301% upside
• Avg. target: $22 310% upside
• High target: $22 320% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

JP Morgan Anupam Rama 0 / 0 met price target	320% upside $22	Overweight Maintained	26 Feb 2025
HC Wainwright & Co. Robert Burns 13% 1-year accuracy 1 / 8 met price target	301% upside $21	Buy Reiterated	26 Feb 2025